Mizuho Initiates Coverage On Eloxx Pharmaceuticals with Buy Rating, Announces Price Target of $3.1
Mizuho analyst Difei Yang initiates coverage on Eloxx Pharmaceuticals (NASDAQ:ELOX) with a Buy rating and announces Price Target of $3.1.
44 Biggest Movers From Yesterday
Gainers
Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at $5 per share.
34 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80.
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 14)
22 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Unique Fabricating, Inc. (NASDAQ: UFAB) rose 43.1% to $4.68 in pre-market trading after the company announced the extension of its Forbearance Agreement with its Lenders through February 28, 2022.
74 Biggest Movers From Friday
Gainers
MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter.
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 13)